Home
Conditions
Neoplasms, Connective Tissue

Clinical trial condition

Neoplasms, Connective Tissue

Explore clinical trials studying Neoplasms, Connective Tissue. Study availability and eligibility vary by location and protocol.

1,267 public trials 270 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Connective Tissue trial results

Completed

Liposomal Doxorubicin Plus Ifosfamide in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

NCT00030784

Conditions: Fibrosarcoma, Hemangiopericytoma, Malignant, Hemangiosarcoma, +27 more
Locations: Aarhus University Hospital - Aarhus Sygehus - Norrebrogade Aarhus, Denmark

Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch Berlin, Germany

View Trial Details

Completed

Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma

NCT00052754

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, +3 more
Locations: Cliniques Universitaires Saint-Luc Brussels, Belgium

U.Z. Gasthuisberg Leuven, Belgium

Institut Bergonie Bordeaux, France

Centre Leon Berard Lyon, France

View all 16 locations

View Trial Details

Completed

Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma

NCT00085475

Conditions: Fibrosarcoma, Histiocytoma, Histiocytoma, Malignant Fibrous, +6 more
Locations: Institut Jules Bordet Brussels, Belgium

U.Z. Gasthuisberg Leuven, Belgium

Institut Bergonie Bordeaux, France

CHU de la Timone Marseille, France

View Trial Details

Completed

Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

NCT00400569

Conditions: Digestive System Diseases, Digestive System Neoplasms, Fibrosarcoma, +16 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)

NCT00171977

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations: Novartis Investigative Site Tokyo, Japan

View Trial Details

Completed

Aerosol L9-NC and Temozolomide in Ewing's Sarcoma

NCT00492141

Conditions: Ewing's Sarcoma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Gastrointestinal Stromal Tumors (GIST) Registry

NCT00507273

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma

NCT00504140

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +4 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Mifepristone for Patients With Endometrial Cancer and LGESS

NCT00505739

Conditions: Endometrial Cancer, Endometrial Neoplasms, Endometrial Stromal Tumors, +15 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

NCT00041236

Conditions: Fibrosarcoma, Hemangiopericytoma, Malignant, Hemangiosarcoma, +25 more
Locations: Cliniques Universitaires Saint-Luc Brussels, Belgium

U.Z. Gasthuisberg Leuven, Belgium

Aarhus University Hospital - Aarhus Sygehus - Norrebrogade Aarhus, Denmark

Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch Berlin, Germany

View Trial Details

Neoplasms, Connective Tissue

Neoplasms, Connective Tissue trial results

Related conditions